Bibliography
- DE CLERCQ E: New anti-HIV agents and targets. Med. Res. Rev (2002) 22:531–565.
- ••An excellent review on antiviral agentstargeting different viral (and mainly HIV) infections.
- SCOZZAFAVA A, OWA T, MASTROLORENZO A, SUPURAN CT: Anticancer and antiviral sulfonamides. Carr. Med. Chem. (2003) 10:1241–1260.
- DE CLERCQ E: Antiviral drugs — current state of the art. Clin. Vim/. (2001) 22:73–89.
- VELLA S, PALMISANO L: Antiretroviraltherapy: state of the HAART Antiviral Res. (2000) 45:1–7.
- JOLY V, YENY P: New trends in antiretroviral therapy of HIV infection. Ear: J. Int. Med. (2000) 11:301–308.
- KAUFMANN GR, COOPER DA: Antiretroviral therapy of HIV-1 infection: established treatment strategies and new therapeutic options. Curt: Opin. Microbial. (2000) 3:508–514.
- NO AUTHORS LISTED: Protease Inhibitors M AIDS Therapy Ogden RC, Flexner CW (Eds), Marcel Dekker, New York, Basel (2001).
- SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Agents that target cysteine residues of biomolecules and their therapeutic potential. Expert Opin. Ther. Patents (2001) 11:765–787.
- MASTROLORENZO A, SCOZZAFAVA A, SUPURAN CT: Small molecule antagonists of chemokine receptors as emerging anti-HIV agents. Expert Opin. Ther. Patents (2001) 11:1245–1252.
- SCOZZAFAVA A, MASTROLORENZO A, SUPURAN CT: Non-peptic chemokine receptors antagonists as emerging anti-HIV agents. Enz. Inhib. Med. Chem. (2002) 17:69-76. Patent details